Edit |   |
---|---|
Antigenic Specificity | Arginase-1, Human |
Clone | REAL1137 |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | n/a |
Format | phycoerythrin (PE) conjugate |
Size | 200 µL |
Concentration | n/a |
Applications | MICS (MACSima Imaging Cyclic Staining), Immunohistochemistry, Immunofluorescence |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Arginase-1 Antibody, anti-human, PE, REAdye_lease™. Clone REAL1137 is an antibody fragment derived from the full Arginase-1 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL1137 recognizes the isoenzyme Arginase-1, also known as ARG1, which is a member of the ureohydrolase family of enzymes. Arginase-1 converts L-arginine into L-ornithine and urea, which is then converted to polyamine. This process takes place primarily in the liver and, to a lesser extent, in the kidneys. Arginase -1 is also expressed in granulocytes, neural stem cells, and in myeloid derived suppressor cells (MDSC) and plays a role in the antimicrobial effector pathway in polymorphonuclear granulocytes. Mutations, which cause Arginase deficiency, can lead to defects in the urea cycle with hyperammonaemia. Arginase-1 is reported to be expressed in colorectal cancer and is found in the majority of hepatocellular carcinomas. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). |
Immunogen | n/a |
Other Names | Arginase 1, Liver-type arginase, ARG1 |
Gene, Accession # | n/a |
Catalog # | 130-127-839 |
Price | $460 |
Order / More Info | Arginase-1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Wu, G. et al. (1998) Arginine metabolism: nitric oxide and beyond. Biochem. J. 336 (Pt 1): 1-17. | Oberlies, J. et al. (2009) Regulation of NK cell function by human granulocyte arginase. J Immunol 182 (9): 5259-5267. | You, J. et al. (2018) The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma. Biomed Res Int: 2109865. | Ma, Z. et al. (2019) Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer. Pathol Res Pract 215 (6): 152383. |